KBG Past Earnings Performance
Past criteria checks 4/6
KBG has been growing earnings at an average annual rate of 35%, while the Chemicals industry saw earnings growing at 6.9% annually. Revenues have been growing at an average rate of 4.9% per year. KBG's return on equity is 10.8%, and it has net margins of 20.4%.
Key information
35.0%
Earnings growth rate
35.6%
EPS growth rate
| Chemicals Industry Growth | 13.9% |
| Revenue growth rate | 4.9% |
| Return on equity | 10.8% |
| Net Margin | 20.4% |
| Last Earnings Update | 30 Jun 2024 |
Recent past performance updates
Recent updates
The Market Doesn't Like What It Sees From KBG Corp.'s (KOSDAQ:318000) Earnings Yet As Shares Tumble 29%
Aug 06
We Think That There Are Some Issues For KBG (KOSDAQ:318000) Beyond Its Promising Earnings
May 21If You Had Bought Korea Bio-GenLtd (KOSDAQ:318000) Stock A Year Ago, You Could Pocket A 33% Gain Today
Mar 02The Trends At Korea Bio-GenLtd (KOSDAQ:318000) That You Should Know About
Feb 03
Should You Be Impressed By Korea Bio-Gen Co.,Ltd's (KOSDAQ:318000) ROE?
Dec 29Calculating The Intrinsic Value Of Korea Bio-Gen Co.,Ltd (KOSDAQ:318000)
Dec 02Revenue & Expenses Breakdown
How KBG makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Jun 24 | 23,204 | 4,736 | 2,075 | 993 |
| 31 Mar 24 | 22,382 | 5,005 | 1,941 | 883 |
| 31 Dec 23 | 21,589 | 4,583 | 1,907 | 837 |
| 30 Sep 23 | 22,166 | 3,671 | 1,907 | 820 |
| 30 Jun 23 | 22,998 | 3,841 | 1,894 | 829 |
| 31 Mar 23 | 23,752 | 2,976 | 1,957 | 871 |
| 31 Dec 22 | 24,346 | 3,252 | 1,952 | 1,072 |
| 30 Sep 22 | 26,897 | 4,487 | 2,015 | 1,150 |
| 30 Jun 22 | 27,525 | 4,054 | 2,004 | 1,248 |
| 31 Mar 22 | 27,398 | 4,246 | 1,907 | 1,373 |
| 31 Dec 21 | 27,201 | 4,004 | 1,840 | 1,182 |
| 30 Sep 21 | 24,530 | 4,038 | 1,716 | 1,099 |
| 30 Jun 21 | 23,138 | 4,059 | 1,627 | 1,093 |
| 31 Mar 21 | 20,765 | 3,331 | 1,561 | 1,023 |
| 31 Dec 20 | 19,788 | 3,123 | 1,443 | 977 |
| 30 Sep 20 | 19,428 | 3,051 | 1,347 | 867 |
| 30 Jun 20 | 18,408 | -1,355 | 1,351 | 796 |
| 31 Mar 20 | 19,152 | -1,223 | 1,324 | 765 |
| 31 Dec 19 | 18,526 | -1,405 | 1,278 | 718 |
| 30 Sep 19 | 18,348 | -1,932 | 1,241 | 565 |
| 31 Mar 19 | 17,363 | 2,230 | 1,067 | 869 |
| 31 Dec 18 | 16,434 | 2,130 | 971 | 850 |
| 31 Dec 17 | 14,406 | 1,641 | 933 | 959 |
| 31 Dec 16 | 13,132 | 1,561 | 806 | 894 |
| 31 Dec 15 | 12,989 | 1,260 | 873 | 609 |
| 31 Dec 14 | 12,628 | 897 | 724 | 651 |
| 31 Dec 13 | 15,107 | 1,410 | 729 | 516 |
Quality Earnings: A318000 has high quality earnings.
Growing Profit Margin: A318000's current net profit margins (20.4%) are higher than last year (16.7%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: A318000's earnings have grown significantly by 35% per year over the past 5 years.
Accelerating Growth: A318000's earnings growth over the past year (23.3%) is below its 5-year average (35% per year).
Earnings vs Industry: A318000 earnings growth over the past year (23.3%) exceeded the Chemicals industry 2.5%.
Return on Equity
High ROE: A318000's Return on Equity (10.8%) is considered low.